Global Patent Index - EP 2465950 A2

EP 2465950 A2 20120620 - K-RAS MUTATIONS AND ANTI-EGFR ANTIBODY THERAPY

Title (en)

K-RAS MUTATIONS AND ANTI-EGFR ANTIBODY THERAPY

Title (de)

K-RAS-Mutationen und Anti-EGFR-Antikörpertherapie

Title (fr)

Mutations de K-RAS et traitement avec des anticorps anti-EGFR

Publication

EP 2465950 A2 20120620 (EN)

Application

EP 12154109 A 20080311

Priority

  • EP 08742061 A 20080311
  • US 90694307 P 20070313

Abstract (en)

The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors.

IPC 8 full level

C12Q 1/68 (2006.01)

CPC (source: EP US)

C12Q 1/6886 (2013.01 - EP US); C12Q 2600/118 (2013.01 - EP US)

Citation (applicant)

  • WO 9824893 A2 19980611 - ABGENIX INC [US]
  • WO 9850433 A2 19981112 - ABGENIX INC [US]
  • US 6235883 B1 20010522 - JAKOBOVITS AYA [US], et al
  • US 2004033543 A1 20040219 - SCHWAB GISELA [US], et al
  • US 5151510 A 19920929 - STEC WOJCIECH J [PL], et al
  • US 5500362 A 19960319 - ROBINSON RANDY R [US], et al
  • US 5821337 A 19981013 - CARTER PAUL J [US], et al
  • US 5470705 A 19951128 - GROSSMAN PAUL D [US], et al
  • US 5514543 A 19960507 - GROSSMAN PAUL D [US], et al
  • US 5580732 A 19961203 - GROSSMAN PAUL D [US], et al
  • US 5624800 A 19970429 - GROSSMAN PAUL D [US], et al
  • US 5807682 A 19980915 - GROSSMAN PAUL DAVID [US], et al
  • US 6759202 B2 20040706 - GROSSMAN PAUL DAVID [US], et al
  • US 6756204 B2 20040629 - GROSSMAN PAUL DAVID [US], et al
  • US 6734296 B1 20040511 - GROSSMAN PAUL D [US]
  • US 6395486 B1 20020528 - GROSSMAN PAUL D [US]
  • US 2003190646 A1 20031009 - WENZ HANS MICHAEL [US], et al
  • WO 2007001868 A1 20070104 - GENENTECH INC [US], et al
  • US 2005272083 A1 20051208 - SESHAGIRI SOMASEKAR [US]
  • ULLRICH ET AL., CELL, vol. 61, 1990, pages 203 - 212
  • BASELGA ET AL., PHARMACOL. THER., vol. 64, 1994, pages 127 - 154
  • MENDELSOHN ET AL.: "Biologic Therapy of Cancer", 1995, J.B. LIPPINCOTT CO., pages: 607 - 623
  • FAN ET AL., CURR. OPIN. ONCOL., vol. 10, 1998, pages 67 - 73
  • MENDELSOHN, CANCER CELLS, vol. 7, 1989, pages 359
  • MENDELSOHN, CANCER BIOLOGY, vol. 1, 1990, pages 339 - 344
  • MODJTAHEDI; DEAN, INT'L J. ONCOLOGY, vol. 4, 1994, pages 277 - 296
  • MODJTAHEDI; DEAN, INT'I J. ONCOLOGY, vol. 4, 1994, pages 277 - 296
  • MENDELSOHN ET AL.: "Bioloqic Therapy of Cancer", 1995, J.B. LIPPINCOTT CO., pages: 607 - 623
  • MODJTAHEDI ET AL., INTL. J. OF ONCOLOGY, vol. 4, 1994, pages 277 - 296
  • GULLICK, BR. MEDICAL BULLETIN, vol. 47, 1991, pages 87 - 98
  • SALOMON ET AL., CRIT. REV. ONCOL. HEMATOL., vol. 19, 1995, pages 183 - 232
  • TOSI ET AL., INT'I J. CANCER, vol. 62, 1995, pages 643 - 650
  • MODJTAHEDI ET AL., INTL. J. ONCOLOGY, vol. 4, 1994, pages 277 - 296
  • ABOUD-PIRAK ET AL., J. NATL. CANCER INST., vol. 80, 1988, pages 1605 - 1611
  • MODJTAJEDI ET AL., INTL. J. ONCOLOGY, vol. 4, 1994, pages 277 - 296
  • MODJTAHEDI ET AL., BR. J. CANCER, vol. 67, 1993, pages 247 - 253
  • MODJTAHEDI ET AL., BR. J. CANCER, vol. 67, 1993, pages 254 - 261
  • MENDELSOHN ET AL.: "Bioloaic Therapy of Cancer", 1995, J.B. LIPPINCOTT CO., pages: 607 - 623
  • FAN ET AL., CANCER RES., vol. 53, 1993, pages 4637 - 4642
  • BASELGA ET AL., J. NATL. CANCER INST., vol. 85, 1993, pages 1327 - 1333
  • GOLDSTEIN ET AL., CLINICAL CANCER RES., vol. 1, 1995, pages 1311 - 1318
  • PREWETT ET AL., J. IMMUNOTHER. EMPHASIS TUMOR IMMUNOL., vol. 19, 1996, pages 419 - 427
  • MENDEZ, NATURE GENETICS, vol. 15, 1997, pages 146 - 156
  • JAKOBOVITS, ADV. DRUG DELIV. REV., vol. 31, no. 1-2, 1998, pages 33 - 42
  • JAKOBOVITS, EXPERT OPIN. INVEST. DRUGS, vol. 7, no. 4, 1998, pages 607 - 614
  • YANG ET AL., CRIT. REV. ONCOL. HEMATOL., vol. 38, no. 1, 2001, pages 17 - 23
  • YANG ET AL., CANCER RES., vol. 59, no. 6, 1999, pages 1236 - 43
  • YAO, R., SCIENCE, vol. 267, 1995, pages 2003 - 2006
  • SAMBROOK ET AL.: "Molecular Cloning: A Laboratory Manual(2d ed., )", 1989, COLD SPRING HARBOR LABORATORY PRESS
  • LAPLANCHE ET AL., NUCL. ACIDS RES., vol. 14, 1986, pages 9081
  • STEC ET AL., J. AM. CHEM. SOC., vol. 106, 1984, pages 6077
  • STEIN ET AL., NUCL. ACIDS RES., vol. 16, 1988, pages 3209
  • ZON ET AL., ANTI-CANCER DRUG DESIGN, vol. 6, 1991, pages 539
  • ZON ET AL.: "Oligonucleotides and Analogues: A Practical Approach", 1991, OXFORD UNIVERSITY PRESS, pages: 87 - 108
  • UHLMANN; PEYMAN, CHEMICAL REVIEWS, vol. 90, 1990, pages 543
  • DAYHOFF, M.O.: "Atlas of Protein Sequence and Structure", vol. 5, 1972, NATIONAL BIOMEDICAL RESEARCH FOUNDATION, pages: 101 - 110
  • SMITH; WATERMAN, ADV. APPL. MATH., vol. 2, 1981, pages 482
  • NEEDLEMAN; WUNSCH, J. MOL. BIOL., vol. 48, 1970, pages 443
  • PEARSON; LIPMAN, PROC. NATL. ACAD. SCI. (U.S.A., vol. 85, 1988, pages 2444
  • E.S. GOLUB AND D.R. GREN,: "Immunology - A Synthesis(2nd Edition,)", 1991, SINAUER ASSOCIATES
  • BRUCE ALBERTS ET AL.: "Molecular Biology of the Cell,4th ed.", 2002, GARLAND PUBLISHING, INC.
  • CREIGHTON,: "Proteins, Structures and Molecular Principles", 1984, W. H. FREEMAN AND COMPANY
  • C. BRANDEN AND J. TOOZE: "Introduction to Protein Structure", 1991, GARLAND PUBLISHING
  • THORNTON, NATURE, vol. 354, 1991, pages 105
  • FAUCHERE, J. ADV. DRUG RES., vol. 15, 1986, pages 29
  • VEBER; FREIDINGER, TINS, 1985, pages 392
  • EVANS ET AL., J. MED. CHEM., vol. 30, 1987, pages 1229
  • RIZO; GIERASCH, ANN. REV. BIOCHEM., vol. 61, 1992, pages 387
  • BOWIE ET AL., SCIENCE, vol. 253, 1991, pages 164
  • CHOTHIA ET AL., J. MOL. BIOL., vol. 186, 1985, pages 651
  • NOVOTNY; HABER, PROC. NATL. ACAD. SCI. U.S.A., vol. 82, 1985, pages 4592
  • CHOTHIA ET AL., NATURE, vol. 342, 1989, pages 877 - 883
  • PLUCKTHUN, IMMUNOL. REV., vol. 130, 1992, pages 151 - 188
  • KABAT ET AL.: "Sequences of Proteins of Immunological Interest, 5th Ed.", 1991, NATIONAL INSTITUTES OF HEALTH
  • CHOTHIA; LESK, J. MOL. BIOL, vol. 196, 1987, pages 901 - 917
  • RAVETCH; KINET, ANNU. REV. IMMUNOL, vol. 9, 1991, pages 457 - 92
  • CLYNES ET AL., PNAS (USA, vol. 95, 1988, pages 652 - 656
  • PARKER, S.,: "The McGraw-Hill Dictionary of Chemical Terms", 1985, MCGRAW-HILL
  • THERASSE ET AL.: "New Guidelines to Evaluate the Response to Treatment in Solid Tumors", J. NATL. CANCER INST., vol. 92, no. 3, February 2000 (2000-02-01), pages 205 - 216
  • SCHIMANSKI ET AL., CANCER RES., vol. 59, 1999, pages 5169 - 5175
  • NAGASAKA ET AL., J. CLIN. ONCOL., vol. 22, 2004, pages 4584 - 4596
  • LIEVRE ET AL., CANCER RES., vol. 66, 2006, pages 3992 - 3994

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA MK RS

DOCDB simple family (publication)

WO 2008112269 A2 20080918; WO 2008112269 A3 20081120; AR 065687 A1 20090624; AU 2008226803 A1 20080918; CA 2680326 A1 20080918; CL 2008000717 A1 20080922; CY 1115333 T1 20170104; CY 1119112 T1 20180214; DK 2121989 T3 20140428; DK 2121989 T4 20220620; DK 2465950 T3 20171009; EP 2121989 A2 20091125; EP 2121989 B1 20140122; EP 2121989 B2 20220309; EP 2465950 A2 20120620; EP 2465950 A3 20130313; EP 2465950 B1 20170712; ES 2458626 T3 20140506; ES 2458626 T5 20220429; ES 2635051 T3 20171002; HR P20140360 T1 20140523; HR P20140360 T4 20220610; HR P20171509 T1 20171117; HU E033695 T2 20171228; JP 2010521153 A 20100624; LT 2465950 T 20171010; MX 2009009787 A 20090922; PE 20081880 A1 20081231; PL 2121989 T3 20140731; PL 2121989 T5 20230306; PL 2465950 T3 20171229; PT 2121989 E 20140430; PT 2465950 T 20171017; RS 53265 B 20140829; RS 53265 B2 20220630; RS 56422 B1 20180131; SI 2121989 T1 20140630; SI 2121989 T2 20220531; SI 2465950 T1 20171130; TW 200902553 A 20090116; US 10030270 B2 20180724; US 11155876 B2 20211026; US 2008293055 A1 20081127; US 2012264129 A1 20121018; US 2019048423 A1 20190214

DOCDB simple family (application)

US 2008003312 W 20080311; AR P080100995 A 20080311; AU 2008226803 A 20080311; CA 2680326 A 20080311; CL 2008000717 A 20080311; CY 141100291 T 20140416; CY 171100792 T 20170725; DK 08742061 T 20080311; DK 12154109 T 20080311; EP 08742061 A 20080311; EP 12154109 A 20080311; ES 08742061 T 20080311; ES 12154109 T 20080311; HR P20140360 T 20080311; HR P20171509 T 20171009; HU E12154109 A 20080311; JP 2009553623 A 20080311; LT 12154109 T 20080311; MX 2009009787 A 20080311; PE 2008000451 A 20080311; PL 08742061 T 20080311; PL 12154109 T 20080311; PT 08742061 T 20080311; PT 12154109 T 20080311; RS P20140187 A 20080311; RS P20170996 A 20080311; SI 200831191 T 20080311; SI 200831873 T 20080311; TW 97108519 A 20080311; US 201213523174 A 20120614; US 201816014056 A 20180621; US 4631908 A 20080311